vs

Side-by-side financial comparison of Community Healthcare Trust Inc (CHCT) and KAMADA LTD (KMDA). Click either name above to swap in a different company.

KAMADA LTD is the larger business by last-quarter revenue ($47.0M vs $31.5M, roughly 1.5× Community Healthcare Trust Inc). KAMADA LTD runs the higher net margin — 11.3% vs 8.1%, a 3.2% gap on every dollar of revenue. On growth, KAMADA LTD posted the faster year-over-year revenue change (12.6% vs 4.8%). Over the past eight quarters, KAMADA LTD's revenue compounded faster (12.0% CAGR vs 7.0%).

Medical Properties Trust, Inc. (MPT) is an international real estate investment trust (REIT) based in Birmingham, Alabama that purchases and invests in healthcare facilities and for-profit healthcare holding companies, primarily in the United States and Europe. Their property acquisitions often come in the form of sale-leaseback agreements, in which the original property owner sells the property to MPT and becomes their tenant. MPT's tenants are generally subject to long-term triple net lease...

Kamada Ltd. is a global biopharmaceutical company specializing in the research, manufacturing, and commercialization of specialty pharmaceuticals derived from human plasma.

CHCT vs KMDA — Head-to-Head

Bigger by revenue
KMDA
KMDA
1.5× larger
KMDA
$47.0M
$31.5M
CHCT
Growing faster (revenue YoY)
KMDA
KMDA
+7.8% gap
KMDA
12.6%
4.8%
CHCT
Higher net margin
KMDA
KMDA
3.2% more per $
KMDA
11.3%
8.1%
CHCT
Faster 2-yr revenue CAGR
KMDA
KMDA
Annualised
KMDA
12.0%
7.0%
CHCT

Income Statement — Q1 FY2026 vs Q3 FY2025

Metric
CHCT
CHCT
KMDA
KMDA
Revenue
$31.5M
$47.0M
Net Profit
$2.5M
$5.3M
Gross Margin
42.0%
Operating Margin
16.6%
Net Margin
8.1%
11.3%
Revenue YoY
4.8%
12.6%
Net Profit YoY
60.2%
37.1%
EPS (diluted)
$0.09

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CHCT
CHCT
KMDA
KMDA
Q1 26
$31.5M
Q4 25
$30.9M
Q3 25
$31.1M
$47.0M
Q2 25
$29.1M
$44.8M
Q1 25
$30.1M
$44.0M
Q4 24
$29.3M
Q3 24
$29.6M
$41.7M
Q2 24
$27.5M
$42.5M
Net Profit
CHCT
CHCT
KMDA
KMDA
Q1 26
$2.5M
Q4 25
$14.4M
Q3 25
$1.6M
$5.3M
Q2 25
$-12.6M
$7.4M
Q1 25
$1.6M
$4.0M
Q4 24
$1.8M
Q3 24
$1.7M
$3.9M
Q2 24
$-10.4M
$4.4M
Gross Margin
CHCT
CHCT
KMDA
KMDA
Q1 26
Q4 25
Q3 25
42.0%
Q2 25
42.3%
Q1 25
47.1%
Q4 24
Q3 24
41.3%
Q2 24
44.6%
Operating Margin
CHCT
CHCT
KMDA
KMDA
Q1 26
Q4 25
Q3 25
16.6%
Q2 25
15.8%
Q1 25
17.7%
Q4 24
Q3 24
12.7%
Q2 24
13.3%
Net Margin
CHCT
CHCT
KMDA
KMDA
Q1 26
8.1%
Q4 25
46.6%
Q3 25
5.3%
11.3%
Q2 25
-43.2%
16.5%
Q1 25
5.3%
9.0%
Q4 24
6.3%
Q3 24
5.9%
9.3%
Q2 24
-37.9%
10.4%
EPS (diluted)
CHCT
CHCT
KMDA
KMDA
Q1 26
Q4 25
$0.52
Q3 25
$0.03
$0.09
Q2 25
$-0.50
$0.13
Q1 25
$0.03
$0.07
Q4 24
$0.04
Q3 24
$0.04
$0.07
Q2 24
$-0.42
$0.08

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CHCT
CHCT
KMDA
KMDA
Cash + ST InvestmentsLiquidity on hand
$2.6M
$72.0M
Total DebtLower is stronger
Stockholders' EquityBook value
$421.3M
$265.2M
Total Assets
$1.0B
$377.2M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CHCT
CHCT
KMDA
KMDA
Q1 26
$2.6M
Q4 25
$3.3M
Q3 25
$3.4M
$72.0M
Q2 25
$4.9M
$66.0M
Q1 25
$2.3M
$76.3M
Q4 24
$4.4M
Q3 24
$2.8M
$72.0M
Q2 24
$734.0K
$56.5M
Total Debt
CHCT
CHCT
KMDA
KMDA
Q1 26
Q4 25
$532.2M
Q3 25
$530.1M
Q2 25
$500.1M
Q1 25
$496.0M
Q4 24
$486.0M
Q3 24
$473.7M
Q2 24
$457.6M
Stockholders' Equity
CHCT
CHCT
KMDA
KMDA
Q1 26
$421.3M
Q4 25
$429.4M
Q3 25
$426.8M
$265.2M
Q2 25
$437.8M
$260.0M
Q1 25
$461.3M
$252.0M
Q4 24
$476.0M
Q3 24
$477.2M
$255.3M
Q2 24
$497.8M
$251.2M
Total Assets
CHCT
CHCT
KMDA
KMDA
Q1 26
$1.0B
Q4 25
$990.8M
Q3 25
$987.3M
$377.2M
Q2 25
$966.3M
$368.2M
Q1 25
$985.1M
$375.1M
Q4 24
$992.6M
Q3 24
$981.8M
$351.2M
Q2 24
$983.2M
$351.0M
Debt / Equity
CHCT
CHCT
KMDA
KMDA
Q1 26
Q4 25
1.24×
Q3 25
1.24×
Q2 25
1.14×
Q1 25
1.08×
Q4 24
1.02×
Q3 24
0.99×
Q2 24
0.92×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CHCT
CHCT
KMDA
KMDA
Operating Cash FlowLast quarter
$10.4M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
1.97×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CHCT
CHCT
KMDA
KMDA
Q1 26
Q4 25
$56.4M
Q3 25
$12.7M
$10.4M
Q2 25
$13.8M
$8.0M
Q1 25
$14.4M
$-513.0K
Q4 24
$58.9M
Q3 24
$13.8M
$22.2M
Q2 24
$16.7M
$14.0M
Free Cash Flow
CHCT
CHCT
KMDA
KMDA
Q1 26
Q4 25
$35.9M
Q3 25
$7.6M
Q2 25
$9.6M
Q1 25
$9.7M
Q4 24
$34.2M
Q3 24
$6.7M
Q2 24
$9.5M
FCF Margin
CHCT
CHCT
KMDA
KMDA
Q1 26
Q4 25
116.0%
Q3 25
24.6%
Q2 25
32.9%
Q1 25
32.3%
Q4 24
116.9%
Q3 24
22.5%
Q2 24
34.7%
Capex Intensity
CHCT
CHCT
KMDA
KMDA
Q1 26
Q4 25
66.3%
Q3 25
16.3%
Q2 25
14.5%
Q1 25
15.6%
Q4 24
84.1%
Q3 24
24.2%
Q2 24
26.1%
Cash Conversion
CHCT
CHCT
KMDA
KMDA
Q1 26
Q4 25
3.91×
Q3 25
7.76×
1.97×
Q2 25
1.09×
Q1 25
9.06×
-0.13×
Q4 24
32.14×
Q3 24
7.92×
5.75×
Q2 24
3.15×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons